Citadel Advisors’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
+355,203
| New | +$130K | ﹤0.01% | 5168 |
|
|
2025
Q1 | – | Sell |
-266,243
| Closed | -$150K | – | 6188 |
|
|
2024
Q4 | $150K | Buy |
+266,243
| New | +$150K | ﹤0.01% | 5009 |
|
|
2024
Q3 | – | Sell |
-40,113
| Closed | -$108K | – | 5999 |
|
|
2024
Q2 | $108K | Sell |
40,113
-1,529,451
| -97% | -$4.13M | ﹤0.01% | 4924 |
|
|
2024
Q1 | $8.05M | Buy |
1,569,564
+978,081
| +165% | +$5.02M | ﹤0.01% | 1419 |
|
|
2023
Q4 | $318K | Sell |
591,483
-248,718
| -30% | -$134K | ﹤0.01% | 4196 |
|
|
2023
Q3 | $557K | Buy |
840,201
+1,607
| +0.2% | +$1.07K | ﹤0.01% | 3637 |
|
|
2023
Q2 | $1.27M | Buy |
+838,594
| New | +$1.27M | ﹤0.01% | 2766 |
|
|
2022
Q1 | – | Sell |
-21,856
| Closed | -$132K | – | 6533 |
|
|
2021
Q4 | $132K | Buy |
+21,856
| New | +$132K | ﹤0.01% | 5747 |
|